In 2012, Lu et al. [21] found, in in vivo and in vitro studies, that HE4 regulated EGFR and Erk1/2 phosphorylation to promote the proliferation of ovarian cancer. The gene discussed is MAPK3; the disease is ovarian carcinoma.